Determination of log P values of new cyclen based antimalarial drug leads using RP-HPLC

Pharmazie

Volumn 69, Issue 9, 2014, Pages 655-662

  Rudraraju, A V ^a   Amoyaw, P N A ^a   Hubin, T J ^a   Khan, M O F ^a  

^a SOUTHWESTERN OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ADENOSINE; AMIODARONE; AMITRIPTYLINE; ANTIMALARIAL AGENT; BUTENAFINE; CHLORPROMAZINE; DRUG SOLVENT; METHANOL; METOCLOPRAMIDE; PENCICLOVIR; PROMETHAZINE; QUINIDINE; QUININE; TACRINE; THIORIDAZINE; TRIPROLIDINE; WATER; CHEMOKINE RECEPTOR CXCR4; LIPID; MACROCYCLIC COMPOUND;

ARTICLE; CALCULATION; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MIXTURE; DRUG STRUCTURE; ELUTION; LIPOPHILICITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STANDARD; STATISTICAL SIGNIFICANCE; CHEMISTRY; DRUG ANTAGONISM; DRUG DEVELOPMENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; STATISTICAL MODEL;

ANTIMALARIALS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DISCOVERY; LINEAR MODELS; LIPIDS; MACROCYCLIC COMPOUNDS; RECEPTORS, CXCR4; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 84908252200     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2014.4019     Document Type: Article

References (56)

1. Abedi, JA (2001) High throughput HPLC method for determining log P values. European Patent Application EP1074836.
2. Abraham MA, Chadha HS, Leitao RA, Mitchell E, Lambert RC, Kaliszan WJ, Nasal R, Haber A (1997) Determination of solute lipophilicity, as log P(octanol) and log P(alkane) using poly(styrene-divinylbenzene) and immobilized artificial membrane stationary phases in reversed-phase high-performance liquid chromatography. J ChromatogrA685: 203-211; 766: 35-47.
3. Avdeef A, (2015) Sirius Technical Application Notes
4. Avdeef A, Takacs-Novak K, Box KJ (1995) pH-metric log P.6. Effects of sodium, potassium, and N-CH3-D-glucamine on the octanol-water partitioning with prostaglandins E1 and E2. J Pharm Sci 84: 523-529.
5. Baum F (1899) Zur Theorie der Alkoholnarkose, Zweite Mittheilung, Ein physikalisch-chemischer, Beitrag Zur Theorie der Narcotica. Arch. Exp Pathol Pharmakol 42: 119-137.
6. Bechalany A, Kakoulidou AT, Tayar NE, Testa B (1991) Measurement of lipophilicity indices by reversed-phase high-performance liquid chromarography: comparision of two stationary phases and various eluents. J Chromatogr 541: 221-229.
7. Berendsen GE, Galan L de (1980) Role of the chain length of chemically bonded phases and the retention mechanism in reversed-phase liquid chromatography. J Chromatogr 196: 21-37.
8. Berthelot M, Jungfleisch E (1872) On the laws that operate for the partition of the substance between two solvents. Ann Chim Phys 26: 396-407.
9. Braumann T (1986) Determination of hydrophobic parameters by reversedphase liquid chromatography: theory, experimental techniques, and application in studies on quantitative structure-activity relationships. J Chromatogr A373: 191-225.
10. Cimpan G, Irimie F, Gocan S, Claessens HA (1998) Role of stationar phase and eluent composition on the determination of log P values of Nhydroxyethylamide of aryloxyalkylen and pyridine carboxylic acids by reversed-phase high-performance liquid chromatography. J Chromatogr B 714: 247-261.
11. Craig P.N. (1990) In Comprehensive Medical Chemistry, Vol. 6, C. Hansch, P.G. Sammes, J. B. Taylor (Eds.), Pergamon Press, Oxford
12. Gould, RF (1972) Biological Correlations - The Hansch Approach. Adv. Chem. Ser. #114. American Chemical Society, Washington, D.C.
13. Hansch C, Leo A (1995) Exploring QSAR. Fundamentals and Applications in Chemistry and Biology.ACS Professional Reference Book, American Chemical Society, Washington, DC.
14. Hansch C, Leo A, Hoekman D (1995) In Exploring QSAR: Hydrophobic, Electronic, and Steric Constants, S. R. Heller (Ed.), American Chemical Society, Washington, DC.
15. Hansch C, Steward AR (1964) The use of substituent constants in the analysis of the structure-activity relationship in penicillin derivatives.J Med Chem 7: 691-694.
16. Hansch, Corwin, Leo A, (1979) Substituent Constants for Correlation Analysis in Chemistry and Biology. New York: John Wiley & Sons Ltd.
17. Hopfinger AJ, Battershe ll RD(1976) Application of SCAP to drug design. 1. Prediction of octanol-water partition coefficients using solvent-dependent conformational analyses. J. Med. Chem. 19: 569-575.
18. Horvath C, Melander W (1977) Liquid chromatography with hydrocarbonaceous bonded phases; theory and practice of reversed phase chromatography J Chromatogr Sci 15: 393-404.
19. Hou TI, Xu XJ (2003) ADME evaluation in drug discovery. 2. Prediction of partition coefficient by atom- additive approach based on atomweighted solvent accessible surface areas. J Chem Inf Comput Sci 43: 1058-1067.
20. Hubin T (2003) Synthesis and coordination chemistry of topologically constrained azamacrocycles J. Coord. Chem. Rev. 241: 27-46.
21. Hubin TJ, AlcockNW, BuschDH(1999) The square pyramidal Pd (II) complex of a cross-bridged tetraazamacrocycle. Acta Cryst. C55: 1404-1406.
22. Hubin TJ, AlcockNW, Clase HJ, BuschDH(2001) Potentiometric titrations and nickel(II) complexes of four topologically constrained tetraazamacrocycles. Supramol. Chem. 13: 261.
23. Hubin TJ, Alcock NW, Clase HJ, Seib L, Busch DH (2002) Synthesis, characterization, and X-ray crystal structures of cobalt(II) and cobalt(III) complexes of four topologically constrained tetraazamacrocycles. Inorg. Chim. Acta337: 91.
24. Hubin TJ, McCormick JM, Collinson SR, Alcock, NW, Clase HJ, Busch D H (2003) Synthesis and X-ray crystal structures of iron(II) and manganese(II) complexes of unsubstituted and benzyl substituted crossbridged tetraazamacrocycles. Inorg. Chim. Acta 346: 76-86.
25. nd edn. (the "Gold Book"). PAC69, 1137.
26. Kaliszan R (1990) High-performance liquid-chromatographic methods and procedures of hydrophobicity determination. Quant Struct Act Relat 9: 83-87.
27. Kaliszan R, Haber P, BaczekTD(2001) Gradient HPLC in the determination of drug lipophilicity and acidity. Pure Appl Chem 73: 1465-1475.
28. Kansy M, Senner F, Gubernator K (1998) Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem 41: 1007-1010.
29. Karger BL, Gant J, Hartkopf A, Weiner PH (1976) Hydrophobic effect in reversed phase liquid chromatography. J Chromatogr 128: 65-78.
30. Khan A, Nicholson G, Greenman J, Madden L, McRobbie G, Pannecouque C, De Clercq E, Silversides JD, Ullom R, Maples DL, Maples RD, Hubin TJ, Archibald SJ (2009) Binding optimization through coordination chemistry: CXCR4 chemokine receptor antagonists form ultrarigid metal complexes. J Am Chem Soc 131:3416-3417.
31. Khan MOF, Levi MS, Tekwani BL, Khan SI, Kimura E, Borne RF (2009)
32. Synthesis and antimalarial activities of cyclen 4-aminoquinoline analogs. Antimicrob Agents Chemother 51: 1320-1324.
33. KubinyiH(1979) Lipophilicity and drug activity. Prog Drug Res 23: 97-198.
34. Lazicek M, Lanznickova A (1995) The effect of lipophilicity on the protein binding and blood cell uptake of some acidic drugs. J Pharm Biomed Anal 13: 823-828.
35. MeyerH(1899) Zur Theorie der Alkoholnarkose. Erste Mittheilung.Welche Eigenschaft der Anaesthetica bedingt ihre narkotischeWirkung. Arch Exp Pathol Pharmakol 42: 109-118.
36. Minick DJ, Frenz JH, Patrick MA, Brent DA (1988) A comprehensive method for determining hydrophobicity constants by reversed-phase high performance liquid chromatography. J Med Chem 31: 1923-1933.
37. Nahum A, Horvath CJ (1981) Surface silanols in silica-bonded hydrocarbonaceous stationary phases: I. Dual retention mechanism in reversed-phase chromatography. J Chromatogr 203: 53-63.
38. Nava-Ocampo AA, Bello-Ramirez AM (2004) Lipophilicity affects the pharmacokinetics and toxicity of local anaesthetic agents administered by caudal block. Clin Exp Pharmacol Physiol 31: 116-118.
39. Overton E (1897) Ueber die osmotischen Eigenschaften der Zelle in ihrer Bedeutung für die Toxikologie und Pharmakologie. Z Phys Chem 22: 189-209.
40. Penniston JT, Beckett L, Bentley DL, Hansch C (1969) Passive permeation of organic compounds through biological tissue: a non-steady-state theory.Mol Pharmacol 5: 333-341.
41. Rutkowska E, Pajak K Jozwiak K (2013) Lipophilicity- Methods of determination and its role in medicinal chemistry. Acta Polon Pharm 70: 3-18.
42. Schoenmakers PJ, Billiet HAH, Galan L de (1981) Systematic study of ternary solvent behavior in reversed phase LC. J Chromatogr 218: 261-184.
43. Seydel JK, Schaper KJ (1982) Quantitative structure-pharmacokinetic relationships and drug design. Pharmacol Ther 15: 131-182.
44. Sharma R, Majer F, Peta VK, Wang J, Keaveney R, Kelleher D, Long A, Gilmer JF (2010) Bile acid toxicity structure-activity relationships: correlations between cell viability and lipophilicity in a panel of new and known bile acids using an oesophageal cell line (HET-1A). Bioorg Med Chem 18: 6886-6895.
45. Smith R, Huskens, Daelemans D, Mewis RE, Garcia CD, Cain AN, Carder Freeman TN, Pannecouque C, De Clercq E, Schols D, Hubin TJ, Archibald SJ (2012) CXCR4 chemokine receptor antagonists: nickel(II) complexes of configurationally restricted macrocycles. Dalton Trans 41: 11369-11377.
46. Spencer RW, Copp LJ, JR Pfister (1985) Inhibition of human leukocyte elastase porcine pancreatic elastase and chymotrypsin by elasnin and other 4-hydroxy-2-pyrones. J Med Chem 28: 1828-1832.
47. Tayar EN, van de Waterbeemd H, Testa B (1985) Measurement of protonated basic compounds by reversed-phase high-performance liquid chromatography: II. Procedure for the determination of a lipophilic index by reversed-phase high- performance liquid chromatography. J Chromatogr 320: 305-312.
48. Terada H (1986) Determination of Log Poct by high-performance liquid chromatography, and its application in the study of quantitative structureactivity relationships. Quant Struct Act Relat 5: 81-88.
49. Testa B, Crivori P, Reist M, Carrupt PA (2000) The influence of lipophilicity on the pharmacokinetic behavior of drugs: concepts andexamples. Perspect Drug Discov 17: 179-211.
50. Timmons JC, Hubin TJ (2010) Preparations and applications of synthetic linked azamacrocycle ligands and complexes. Coord Chem Rev 254:1661-1685.
51. Valks GC, McRobbie G Lewis EA, Hubin TJ, Hunter, TM, Sadler PJ, Pannecouque C, De Clerq E, Archibald SJ (2006) Configurationallyrestricted bismacrocyclic CXCR4 receptor antagonists. J Med Chem 49: 6162-6165.
52. Veith GD, Austin NM, Morris RT (1979) A rapid method for estimating log P for organic chemicals. Water Res 13: 43-47.
53. Vieth GD,Konasewich DE (1975) Structure-Activity Correlations in studies of toxicity and Bio-concentration with Aquatic Organisms. International Joint Commission Publication, Windsor, Ont: 347-362.
54. Walter H, Brooks DE, Fisher D (1985) Partitioning in Aqueous Two phase Systems. Academic Press, London. Waterbeemd H, Dennis A, Jones SBC (2001) Lipophilicity in PK design: methyl, ethyl, futile. J Comput Aided Mol Des 15: 273-286.
55. Weisman FR, Wong EH, Hill DC, Rogers ME, Reed DP, Calabrese JC (1996) Synthesis and transition-metal complexes of new cross-bridged tetraamine ligands. Chem Commun 947-948.
56. Yamana S, Tsuji A, Miyamoto E, Kubo S (1977) Novel method for determination of partition coefficients of penicillins and cephalosporins by high-pressure liquid chromatography. J Pharm Sci 66: 747-749.